Literature DB >> 29164727

Highly Efficient Synthesis of a Staphylococcus aureus Targeting Payload to Enable the First Antibody-Antibiotic Conjugate.

Xin Linghu1, Nathaniel L Segraves2, Ifat Abramovich2, Nicholas Wong1, Barbara Müller1, Nadja Neubauer1, Serena Fantasia3, Sebastian Rieth3, Stephan Bachmann3, Michael Jansen3, C Gregory Sowell1, David Askin1, Stefan G Koenig1, Francis Gosselin1.   

Abstract

A practical synthesis of the complex payload for an anti-Staphylococcus aureus THIOMABTM antibody-antibiotic conjugate (TAC) is described. The route takes advantage of a delicate oxidative condensation, achieved using a semi-continuous flow procedure. It allows for the generation of kilogram quantities of a key intermediate to enable a mild nucleophilic aromatic substitution to the tertiary amine free drug. The linker component is introduced as a benzylic chloride, which allows formation of the quaternary ammonium salt linker-drug. This chemical process surmounts numerous synthetic challenges and navigates deeply colored and unstable compounds to support clinical studies to counter S. aureus bacterial infections.
© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  antibiotics; bacteria; flow chemistry; oxidation; semi-continuous

Mesh:

Substances:

Year:  2017        PMID: 29164727     DOI: 10.1002/chem.201705392

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  3 in total

1.  Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics.

Authors:  James Peek; Bimal Koirala; Sean F Brady
Journal:  Bioorg Med Chem Lett       Date:  2021-11-30       Impact factor: 2.823

Review 2.  Monoclonal Antibodies as an Antibacterial Approach Against Bacterial Pathogens.

Authors:  Daniel V Zurawski; Molly K McLendon
Journal:  Antibiotics (Basel)       Date:  2020-04-01

Review 3.  Antibiotics in the clinical pipeline in October 2019.

Authors:  Mark S Butler; David L Paterson
Journal:  J Antibiot (Tokyo)       Date:  2020-03-10       Impact factor: 2.649

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.